Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Loughran

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
AIDS Research and Human Retroviruses|October 9, 2014
Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
Virology Journal|December 25, 2013
Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Blood|June 23, 2023
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemiaJonathan E Brammer, Karen Ballen, Lubomir Sokol, et al.
Nature Communications|April 12, 2022
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8<sup>+</sup> T-cell large granular lymphocytic leukemiaJani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, et al.
Clinical Lymphoma|July 2, 2005
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim reportSattva S Neelapu, Barry L Gause, Daniel A Nikcevich, et al.
The New England Journal of Medicine|March 1, 2002
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemiaHagop Kantarjian, Charles Sawyers, Andreas Hochhaus, et al.
Research Square|June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologyMichelle Churchman, Xin Lu, David McKean, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
AIDS Research and Human Retroviruses|October 9, 2014
Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
Virology Journal|December 25, 2013
Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Blood|June 23, 2023
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemiaJonathan E Brammer, Karen Ballen, Lubomir Sokol, et al.
Nature Communications|April 12, 2022
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8<sup>+</sup> T-cell large granular lymphocytic leukemiaJani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, et al.
Clinical Lymphoma|July 2, 2005
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim reportSattva S Neelapu, Barry L Gause, Daniel A Nikcevich, et al.
The New England Journal of Medicine|March 1, 2002
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemiaHagop Kantarjian, Charles Sawyers, Andreas Hochhaus, et al.
Research Square|June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologyMichelle Churchman, Xin Lu, David McKean, et al.
Pageof 2